FATE Competitors & Alternatives
Compare Fate Therapeutics Inc with similar stocks in the same industry
Biotechnology
FATE
Main Stock$1.96
Tradestie Score
55
Market Cap
$144.16M
Revenue Growth
-0.2%
Analyst Upside
+176.2%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.44
|
$293.03M | - | 60 | Compare |
|
OMER
Omeros Corporation
|
$9.23
|
$281.75M | 8.9 | 45 | Compare |
|
DBVT
DBV Technologies S.A.
|
$17.95
|
$275.54M | - | 59 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.96
|
$275.13M | - | 49 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$13.61
|
$269.08M | - | 48 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.58
|
$211.22M | - | 55 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.51
|
$202.58M | - | 58 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$17.53
|
$199.71M | - | 47 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.69
|
$170.45M | - | 48 | Compare |
More FATE Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry